Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2018

SAPIEN M3 Transcatheter Mitral Valve Replacement System: 30-Day Outcomes From the US Early Feasibility Study

Presenter: Charles J. Davidson, Francesco Maisano, Raj Makkar

September 24, 2018

Presentation TCT 2018

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

Presenter: Rebecca T. Hahn, Jose Luis Navia, Maurizio Taramasso, Henryk Dreger

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

Conductor (Illustrative Cases)

Presenter: Tamim Nazif

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, John G. Webb

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Conductor (Illustrative Cases)

Presenter: John Forrest

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Combined TAVR With Sapien 3 Valve and Paravalvular Leak Closure for Severe Paravalvular Leak

Presenter: A. Pieter Kappetein, Dee Dee Wang, Cenap Undemir, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Presenter: Howard C. Herrmann, Fabian Nietlispach, Hasan Ahmad, MD

June 21, 2018

Presentation EuroPCR 2018

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Presenter: E. Murat Tuzcu

May 25, 2018

Presentation

Sex-Specific Outcomes of TAVR With the SAPIEN 3 Valve

January 05, 2018

Advertisement

SAPIEN M3 Transcatheter Mitral Valve Replacement System: 30-Day Outcomes From the US Early Feasibility Study

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

Conductor (Illustrative Cases)

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Conductor (Illustrative Cases)

Combined TAVR With Sapien 3 Valve and Paravalvular Leak Closure for Severe Paravalvular Leak

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Sex-Specific Outcomes of TAVR With the SAPIEN 3 Valve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content